Dose-response in the peripheral analgesic activity of metformin in the abdominal writhing test in mice
DOI:
https://doi.org/10.24265/horizmed.2018.v18n2.07Keywords:
Metformin, Pain, Analgesics, Peripheral nervous system, RodentAbstract
Objective: To evaluate the dose-response analgesic effect of metformin in an acute pain event in rodents. Materials and methods: Eighty (80) mice were used. The analgesic effect was evaluated using the abdominal writhing test in mice. Eight (8) groups of 10 mice each were formed: one diclofenac 8 mg/kg group, one tramadol group, one target group, and five experimental groups of metformin at doses of 50, 100, 150, 200 and 250 mg/kg. For the statistical analysis, the D'Agostino-Pearson test, one-tailed ANOVA test, Tukey's test, and Pearson's correlation coefficient were used. Results: The D'Agostino-Pearson normality test revealed a p-value < 0.05 in all groups. The ANOVA test showed a p-value < 0.0001. The Tukey's range test obtained a p-value < 0.05 between the target group and metformin groups at all doses, and between the diclofenac group and metformin groups at doses of 100, 150, 200 and 250 mg/kg, and a p-value > 0.05 between the tramadol group and metformin groups at doses of 100, 150, 200 and 250 mg/kg. The Pearson's correlation coefficient was r = -0.6897 and R = 0.4756, and yielded a p-value < 0.0001. Metformin showed a pain inhibition percentage in the range of 34.89 % to 92.62 %. Conclusions: It has been demonstrated that metformin at doses of 100, 150, 200 and 250 mg/kg had an acute analgesic effect in the abdominal writhing test in mice, with the 250 mg/kg dose being the one that showed the best effect. In addition, a dose-response effect was obtained in escalated doses of metformin.
Downloads
References
Schacht AL, Munos BH, Persinger CC, Dunwiddie CT, Mytelka DS, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9(3):203.
Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas A, Hufeisen SJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175–81.
Sirven JI. New Uses for Older Drugs: The Tales of Aspirin, Thalidomide, and Gabapentin. Mayo Clin Proc. 2010;85(6):508–11.
Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10(5):501–7.
Lamanna C, Monami M, Marchionni N, Mannucci E. Effect of metformin on cardiovascular events and mortality: a meta- analysis of randomized clinical trials. Diabetes Obes Metab. 2011;13(3):221–8.
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial. Ann Intern Med. 2005;142(8):611.
Alexánderson-Rosas E, Martínez A de J, Ochoa-López JM, Calleja-Torres R, Sierra-Fernández C, Iñarra-Talboy F, et al. Efecto del tratamiento combinado con metformina/ glimepirida sobre la función endotelial en pacientes con diabetes mellitus tipo 2 evaluados mediante PET. Arch Cardiol México. 2009;79(4):149–256.
Montes J, Pacheco K, Figueroa J, Inga V, Ortega Y, Flores C, et al. Análisis de la actividad antiinflamatoria y analgésica aguda de la metformina mediante el Test de Formalina. Horiz Méd. 2012;12(2).
Koh S-J, Kim JM, Kim I-K, Ko SH, Kim JS. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer. J Gastroenterol Hepatol. 2014;29(3):502–10.
Guppy A, Jamal-Hanjani M, Pickering L. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Future Oncol Lond Engl. 2011;7(6):727–36.
DeCensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, et al. Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. Cancer Prev Res (Phila Pa). 2010;3(11):1451–61.
Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission. Cancer Res. 2009;69(19):7507–11.
Gonzalez-Angulo AM, Meric-Bernstam F. Metformin: A therapeutic opportunity in breast cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2010;16(6):1695–700.
Cefalu WT, Buse JB, Prato SD, Home PD, LeRoith D, Nauck MA, et al. Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care. 2014;37(9):2647–59.
Current Protocols in Pharmacology [Internet]. [citado el 26 de noviembre de 2017]. Disponible en: http://onlinelibrary.wiley.com/book/10.1002/0471141755/homepage/Archive.html
Moreno C, Prada DM. Fisiopatología del dolor clínico. Guía Neurológica. 2004;3:9–21.
Galduf J, Gallego C, Escrivá J, Montserrat V. Ensayos clínicos: Elaboración de una lista-guía para la valoración de protocolos. Farm Hosp. 1995;19(1):17–23.
Mujica J PY. Procesamiento de señales in vivo, edición audivisual y creación de un prototipo de software educativo para simulación de experimentos en farmacología. [Tesis para optar el grado de Bachiller en Ingenería Electrónica.]. [Lima]: Universidad San Martín de Porres; 2009.
Microlabs for Pharmacologists [Internet]. [citado el 28 de noviembre de 2017]. Disponible en: https://norecopa.no/norina/microlabs-for-pharmacologists
Research NRC (US) I for LA. International Guiding Principles for Biomedical Research Involving Animals (1985) [Internet]. National Academies Press (US); 2004 [citado el 27 de noviembre de 2017]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK25438/
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109–10.
Taylor A, Westveld AH, Szkudlinska M, Guruguri P, Annabi E, Patwardhan A, et al. The use of metformin is associated with decreased lumbar radiculopathy pain. J Pain Res.2013;6:755–63.
Ma J, Yu H, Liu J, Chen Y, Wang Q, Xiang L. Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur J Pharmacol. 2015;764(Supplement C):599–606.
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).